|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61K 31/505 | (2013.01) | ||
| A61P 15/10 | (2006.01) | ||
| A61P 15/10 | (2018.01) |
| (11) | Patento numeris | 3654983 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18740208.6 |
| Europos patento paraiškos padavimo data | 2018-07-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-05-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/068992 |
| Data | 2018-07-12 |
| (87) | Numeris | WO 2019/016074 |
| Data | 2019-01-24 |
| (30) | Numeris | Data | Šalis |
| 201762533448 P | 2017-07-17 | US |
| (72) |
WHITTAKER, Andrew , GB
SANGANEE, Hitesh, Jayantilal , GB
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | MPO INHIBITORS FOR USE IN MEDICINE |
| MPO INHIBITORS FOR USE IN MEDICINE |